NOBILI, STEFANIA

NOBILI, STEFANIA  

Neuroscienze, Area del Farmaco e Salute del Bambino (NEUROFARBA)  

Mostra records
Risultati 1 - 20 di 180 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds 2012 F. Guidi; M. Puglia; C. Gabbiani; I. Landini; T. Gamberi; D. Fregona; M.A. Cinellu; S. Nobili; E. Mini; L. Bini; P.A. Modesti; A. Modesti; L. Messori
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 2018 Lavacchi D, Nobili S, Brugia M, Paderi A, Fancelli S, Caliman E, Vergoni F, Mini E.
A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy. 2018 De Mattia E, Dreussi E, Montico M, Gagno S, Zanusso C, Quartuccio L, De Vita S, Guardascione M, Buonadonna A, D'Andrea M, Pella N, Favaretto A, Mini E, Nobili S, Romanato L, Cecchin E, Toffoli G.
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development 2019 Roviello G.; Nobili S.; Mini E.
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 2016 Mini, E; D’Aurizio, R; Perrone, G; Magi, A; Lapucci, A; Tassi, R; Napoli, C; Picariello, L; Landini, I; Brugia, M; Mazzei, T; Tonelli, F; Nobili, S
Adjuvant chemotherapy with 5-fluorouracil (5-FU) and folinic acid (L-LV) for colorectal carcinoma: preliminary results of a randomized multicenter study of the Gruppo Cooperativo Oncologico Tosco-Umbro (GCOTU) 1995 Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Nobili S, Mazzoni P
Administering gemcitabine as fixed-dose-rate infusion in combination with cisplatin, potentially effective target plasma concentrations are achieved in patients with advanced non-small cell lung cancer 2007 Marangon E, Sala F, Caffo O, D'Incalci M, Galligioni E, Fallani S, Nobili S, Cassetta M, Mini E, Zucchetti M
Adverse drug reactions in oncoLogy: intEnsive monitoring program on biotechnological anD taRget therapies in Oncologic patientS-ALEXANDROS observational study 2017 Nobili S, Mini, E, Mazzei T, Vannacci A
Adverse drug reactions in oncoLogy: intEnsive monitoring program on drug toXicity of biotechnological medicatioNs anD taRget therapies in Oncologic patientS - the ALEXANDROS observational study 2017 Galiulo M, Convertino I, Blandizzi C, Tassi R, Diacciati S, Nobili S, Capogrosso Sansone A, Marino A, Mini E, Mazzei T, Vannacci A, Parrilli M, Corona T, Tuccori M
Alternative approaches to overcome multidrug resistance 2008 Nobili S; Mini E
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC) 2020 D'Angelo A.; Bagby S.; Di Pierro G.; Chirra M.; Nobili S.; Mini E.; Villari D.; Roviello G.
Analisi dell'espressione di geni coinvolti nella resistenza al 5-fluorouracile nel carcinoma colorettale 2002 Stefania Nobili
Analysis of Gene Expression Profiles Reveals Novel Correlations With the Clinical Course of Colorectal Cancer 2007 D. Cavalieri; P. Dolara; E. Mini; C. Luceri; C. Castagnini; S. Toti; K. Maciag; C. De Filippo; S. Nobili; M. Morganti; C. Napoli; G. Tonini; M. Baccini; A. Biggeri; F. Tonelli; R. Valanzano; C. Orlando; S. Gelmini; F. Cianchi; L. Messerini; L. Luzzatto
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 2018 Magherini, Francesca; Fiaschi, Tania; Valocchia, Elisa; Becatti, Matteo; Pratesi, Alessandro; Marzo, Tiziano; Massai, Lara; Gabbiani, Chiara; Landini, Ida; Nobili, Stefania; Mini, Enrico; Messori, Luigi; Modesti, Alessandra; Gamberi, Tania*
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 2022 Russo, Valentina; Lallo, Eleonora; Munnia, Armelle; Spedicato, Miriana; Messerini, Luca; D'Aurizio, Romina; Ceroni, Elia Giuseppe; Brunelli, Giulia; Galvano, Antonio; Russo, Antonio; Landini, Ida; Nobili, Stefania; Ceppi, Marcello; Bruzzone, Marco; Cianchi, Fabio; Staderini, Fabio; Roselli, Mario; Riondino, Silvia; Ferroni, Patrizia; Guadagni, Fiorella; Mini, Enrico; Peluso, Marco
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer 2020 Roviello G.; Ramello M.; Catalano M.; D'Angelo A.; Conca R.; Gasperoni S.; Dreoni L.; Petrioli R.; Ianza A.; Nobili S.; Aieta M.; Mini E.
Association of the HLA-G 3′UTR polymorphisms with colorectal cancer in Italy: a first insight 2016 Garziera, M; Catamo, E; Crovella, S; Montico, M; Cecchin, E; Lonardi, S; Mini, E; Nobili, S; Romanato, L; Toffoli, G
Bimonthly chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients with metastatic colorectal cancer pretreated with CPT11- or OHP-based CHT 2004 Nobili S; Del Buono S; Mazzocchi V; Filippelli F; Checcacci D; Giglioni B; Mazzei T; Mini E
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic Acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy. 2008 S. Nobili; D. Checcacci; F. Filippelli; S. Del Buono; V. Mazzocchi; T. Mazzei; E. Mini
Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT-11), infusional 5-fluorouracil/folinic acis (FU/FA) in patients (PTS) with metastatic colorectal cancer (MCRC) pretreated with CPT-11- or OHP-based CHT 2003 Mini E; Nobili S; Mazzocchi V; Del Buono S; Scicolone S; Giglioni B; Mazzei T